The Departments of Pathology*, Chest**, Faculty of Medicine, Benha University, Egypt and Department of Pathology***, Faculty of Medicine, Assiut University, Egypt & Almarefa University, KSA
Abstract Background: The differentiation between benign and malignant mesothelial cells in pleural effusion in some cases can be a challenge. In the current study, we investigated the value of immunohistochemistry (IHC) in making that differ-entiation. Aim of Study: This study aims to examine the value of IHC expression of desmin, EMA, GLUT-1, p53, Ki67, and BAP1 in discrimination between benign and malignant mes-othelial proliferation in pleural effusions and compare their results regarding sensitivity and specificity. Material and Methods: Pleural fluids from 30 cases diagnosed as malignant meothelioma (MM) epitheloid type and 20 cases diagnosed as reactive mesothelial hyperplasia (RMH) were selected, and stained with immunohistochemical stains included BAP-1, desmin, epithelial membrane antigen (EMA), glucose-transport protein 1 (GLUTÅ]1), Ki67, and p53. Results: BAP-1 was negative in 5% (1 of 20) cases of reactive MH and in 63.3% (19 of 30) of MM cases (p<.005). GLUTÅ] 1 was positive in 15% (3 of 20) of benign and 70% (21 of 30) of malignant cases (p<.005). Desmin was positive in 80% (16 of 20) cases of reactive MH and in 10% (3 of 30) of MM cases (p<.001). EMA was positive in 10% (2 of 20) of benign and 96.7% (29 of 30) of malignant cases (p<.001). P53 showed strong nuclear positivity in 5% (1 of 20) of benign and 53.3% (16 of 30) of malignant cases (p<.001). Ki67 showed strong nuclear positivity in >40% of mesothelial cells in 10% (2 of 20) of benign and 16.7% (5 of 30) of malignant cases (p=0.40). EMA negativity and desmin positivity were found in 75% (15 of 20) of reactive MH cases and 3.3% (one of 30) of MM cases. EMA positivity and desmin negativity were found in 5% (1 of 20) of reactive MH cases and 90% (27 of 30) of MM cases (p<.001). Positivity for both of Desmin and BAP-1 was detected in 80% (16 of 20) of RMH cases. The combination of Desmin and BAP-1 negativity was detected in 60% (16 of 30) of MM cases (p-value p<.001). Conclusions: Cases showed positivity for EMA and neg-ativity for desmin strongly favors malignant mesothelioma. On the contrary, cases showed negative EMA and positive desmin strongly favors Reactive mesothelial hyperplasia. also the combination of Desmin and Bap-1 postivity favors diagnosis of RMH, and the combination of Desmin and BAP-1 negativity favors the diagnosis of MM. Similarly, cases showed strong membranous expression of GLUT-1 and/or strong nuclear expression of p53 strongly favors diagnosis of malignant mesothelioma. Proliferative index showed detected by Ki67 showed no significant difference between reactive and malignant cases.
MOHAMMED ELMAHDY, M.D., M. H. G. M., & ELOSEILY, M.D., G. M. (2019). Immunohistochemical Differentiation between Reactive and Malignant Mesothelial Proliferations in Pleural Effusion. The Medical Journal of Cairo University, 87(December), 4345-4353. doi: 10.21608/mjcu.2019.78251
MLA
MOHEBAT H. GOUDA, M.D.; MOHAMMED ELMAHDY, M.D.; GEHAN M. ELOSEILY, M.D.. "Immunohistochemical Differentiation between Reactive and Malignant Mesothelial Proliferations in Pleural Effusion", The Medical Journal of Cairo University, 87, December, 2019, 4345-4353. doi: 10.21608/mjcu.2019.78251
HARVARD
MOHAMMED ELMAHDY, M.D., M. H. G. M., ELOSEILY, M.D., G. M. (2019). 'Immunohistochemical Differentiation between Reactive and Malignant Mesothelial Proliferations in Pleural Effusion', The Medical Journal of Cairo University, 87(December), pp. 4345-4353. doi: 10.21608/mjcu.2019.78251
VANCOUVER
MOHAMMED ELMAHDY, M.D., M. H. G. M., ELOSEILY, M.D., G. M. Immunohistochemical Differentiation between Reactive and Malignant Mesothelial Proliferations in Pleural Effusion. The Medical Journal of Cairo University, 2019; 87(December): 4345-4353. doi: 10.21608/mjcu.2019.78251